Evidence map›Paper›PMID 37277468›Full record

ArticleNature chemical biology2023

A multi-enzyme machine polymerizes the Haemophilus influenzae type b capsule.

Javier O Cifuente, Julia Schulze, Andrea Bethe, Valerio Di Domenico, Christa Litschko, Insa Budde, Lukas Eidenberger, Hauke Thiesler, Isabel Ramón Roth, Monika Berger and 7 more

Open access · hybridAbstract read
In one paragraph

Article in Nature chemical biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 7 institutions in 3 countries.

Javier O Cifuente *Structural Glycobiology Laboratory, Biocruces Bizkaia Health Research Institute, Cruces University Hospital, Barakaldo, Spain.ORCID http://orcid.org/0000-0001-5420-121X
Julia Schulze *Institute of Clinical Biochemistry, Hannover Medical School, Hannover, Germany.ORCID http://orcid.org/0000-0002-8765-6672
Andrea Bethe *Institute of Clinical Biochemistry, Hannover Medical School, Hannover, Germany.
Valerio Di Domenico *Structural Glycobiology Laboratory, Biocruces Bizkaia Health Research Institute, Cruces University Hospital, Barakaldo, Spain.ORCID http://orcid.org/0000-0002-8040-5854
Christa LitschkoInstitute of Clinical Biochemistry, Hannover Medical School, Hannover, Germany.ORCID http://orcid.org/0000-0001-9114-4832
Insa BuddeInstitute of Clinical Biochemistry, Hannover Medical School, Hannover, Germany.
Lukas EidenbergerDepartment of Applied Genetics and Cell Biology, University of Natural Resources and Life Sciences, Vienna, Austria.ORCID http://orcid.org/0000-0002-9491-1416
Hauke ThieslerInstitute of Clinical Biochemistry, Hannover Medical School, Hannover, Germany.ORCID http://orcid.org/0000-0001-5561-3988
Isabel Ramón RothInstitute of Clinical Biochemistry, Hannover Medical School, Hannover, Germany.
Monika BergerInstitute of Clinical Biochemistry, Hannover Medical School, Hannover, Germany.
Heike ClausInstitute for Hygiene and Microbiology, University of Würzburg, Würzburg, Germany.ORCID http://orcid.org/0000-0002-7585-8533
Cecilia D'AngeloStructural Glycobiology Laboratory, Biocruces Bizkaia Health Research Institute, Cruces University Hospital, Barakaldo, Spain.ORCID http://orcid.org/0000-0001-9645-8056
Alberto MarinaStructural Glycobiology Laboratory, Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), Bizkaia Technology Park, Derio, Spain.ORCID http://orcid.org/0000-0001-7822-0503
Rita Gerardy-SchahnInstitute of Clinical Biochemistry, Hannover Medical School, Hannover, Germany.ORCID http://orcid.org/0000-0002-5796-368X
Mario SchubertDepartment of Biosciences and Medical Biology, University of Salzburg, Salzburg, Austria.ORCID http://orcid.org/0000-0003-0278-4091
Marcelo E GuerinStructural Glycobiology Laboratory, Biocruces Bizkaia Health Research Institute, Cruces University Hospital, Barakaldo, Spain. mrcguerin@gmail.com.ORCID http://orcid.org/0000-0001-9524-3184
Timm FiebigInstitute of Clinical Biochemistry, Hannover Medical School, Hannover, Germany. fiebig.timm@mh-hannover.de.ORCID http://orcid.org/0000-0002-2021-7296
Medizinische Hochschule Hannover · DEBioCruces Health research Institute · ESCIC bioGUNE · ESBOKU University · ATIkerbasque · ESUniversity of Salzburg · ATUniversity of Würzburg · DE

Funding

Rationalizing glycoengineering strategies for immunotherapeutic antibodiesR01AI149297 · NIAID · EMORY UNIVERSITY · PI JEFFREY Victor RAVETCH, ERIC JOHN SUNDBERG · 2020 to 2026
$3.7M
NIAID NIH HHS R01 AI149297
6 · The paper itself

Abstract

Bacterial capsules have critical roles in host-pathogen interactions. They provide a protective envelope against host recognition, leading to immune evasion and bacterial survival. Here we define the capsule biosynthesis pathway of Haemophilus influenzae serotype b (Hib), a Gram-negative bacterium that causes severe infections in infants and children. Reconstitution of this pathway enabled the fermentation-free production of Hib vaccine antigens starting from widely available precursors and detailed characterization of the enzymatic machinery. The X-ray crystal structure of the capsule polymerase Bcs3 reveals a multi-enzyme machine adopting a basket-like shape that creates a protected environment for the synthesis of the complex Hib polymer. This architecture is commonly exploited for surface glycan synthesis by both Gram-negative and Gram-positive pathogens. Supported by biochemical studies and comprehensive 2D nuclear magnetic resonance, our data explain how the ribofuranosyltransferase CriT, the phosphatase CrpP, the ribitol-phosphate transferase CroT and a polymer-binding domain function as a unique multi-enzyme assembly.

Indexed as

Haemophilus InfectionsHaemophilus influenzae type bHaemophilus VaccinesBacterial CapsulesChildGram-Negative BacteriaHumansInfantHaemophilus Vaccines

Identifiers

PMID37277468
PMCPMC10299916
OpenAlexW4379471942

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.